The current Amyotrophic Lateral Sclerosis Market Economic Outlook reflects a sector that is increasingly insulated from broader macroeconomic volatility due to the non-discretionary nature of neurodegenerative care. In 2026, the economic value of the market is being bolstered by a "multiplier effect" stemming from public-private partnerships, such as the Accelerating Medicines Partnership in...